Name: 11th International Conference on Clinical Microbiology and Infectious Diseases
Start: 2022-05-27
End: 2022-05-28
Location: Rome, Italy
Rating: 4.6

Renowned Speakers

Dr Ovidiu Zlatian

University of Medicine and Pharmacy of Craiova, Romania Romania

Mr Vincent Xin

Shanghai American School/Shanghai Renji Hospital, Shanghai, China China

Dr Charles Ologunde

The Federal Polytechnic Ado-Ekiti, Nigeria Nigeria

Recommended Global Microbiology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Euro Clinical Microbiology 2022

Theme: Emerging Challenges in Clinical Microbiology

EURO CLINICAL MICROBIOLOGY 2022

The Conference Series LLC Ltd organizes conferences around the world on all medical subjects including microbiology and its related fields. Here we are happy to invite all microbiology researchers/ industrialists/ students to join our "11th International Conference on Clinical Microbiology and Infectious Diseases" which is scheduled to be held in Paris, France during July 19-20, 2021. The Euro Clinical Microbiology 2021 is initiated by the Editors of Journal of Clinical Microbiology: Open Access, Journal of Food & Industrial Microbiology: Open Access, and Journal of Plant Pathology & Microbiology: Open Access.

Details of Euro Clinical Microbiology 2021, Paris, France

Conference Name	Place	Date
EURO CLINICAL MICROBIOLOGY 2022	Rome,Italy	May 27-28,2022

About

Conferenceseries LLC Ltd and its subsidiaries including iMedPub Ltd and Conference Series Organise 3000+ Conferences across USA, Europe& Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology "Open Access", Conferenceseries LLC Ltd publishes scholarly journals in all aspects of Science, Engineering, Management and Technology journals. Conferenceseries LLC Ltd has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. Conferenceseries LLC Ltd also organizes 3000+ International conferences across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.

Market Analysis

Market size is experience significant growth from 2019 to 2025. Increasing prevalence of rare diseases across the world will stimulate rare disease treatment market growth in the coming years. Rare diseases or orphan diseases are conditions that affect a small percentage of population at any given time. According to the U.S. Food & Drug Administration (FDA), an orphan disease is defined as a disease or condition affecting less than 200,000 people in the country. Orphan Drugs Act under the U.S. legislation allows manufacturer to request FDA to grant an orphan drug status to drugs intended to treat a rare disease or condition.

Upcoming for the Rare Disease Drugs industry over the forecast years. Rare Disease Drugs Market report data has been gathered from industry specialist/experts. Although the market size of the market is studied and predicted from 2019 to 2028 mulling over 2016 as the base year of the market study. Attentiveness for the market has increased in recent decades due to development and improvement in the innovation

Additionally, rising investment in rare diseases treatment categories and introduction of new drugs will boost the market growth in the coming years. For instance, more than 560 drugs are in development for the treatment of rare disease. Therapies in development include treatment for amyotrophic lateral sclerosis, multiple myeloma, cystic fibrosis and enzyme deficiency disorders. Rising government initiatives for spreading awareness regarding rare diseases along with presence of suitable healthcare infrastructure in developed and developing economies will drive the industry growth. Nearly there are 7,000 different types of Rare Diseases and disorders it has estimated that 30 million people in the United States, 30 million in Europe and 350 million people over the globe suffer from Rare Diseases. Four by fifth of Rare Diseases are genetic in origin, among them affected individuals 50% of them will be children. The Rare Diseases are distributed in such a way that four fifth of the cases accounted by some 350 Rare Diseases. About only 5% of rare diseases are having approved drug treatment with only 326 new drugs being approved from the FDA and brought in to the market.

In 2018, Orphan Drug sales were of the order of 93 billion. Orphan Drugs represented 35% of the industry’s new drug approvals. The genetic diseases are subdivided by therapeutic area, which was leading the global market in the past will show similar traction in the coming next eight years. This segment is anticipated to be valued at US$ 56,241 by the end of 2025. According to Statistics of MRC, the Global Orphan Drug market is estimated at $145.89 million in 2018 and is expected to reach $265.63 million by 2022 growing at a CAGR of 10.5% from 2018 to 2022.

Scientific Sessions

Session 1: Antimicrobial Agents and Resistance:

Antimicrobial Agents:

An antimicrobial is an agent that kills microorganisms or stops their growth. Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used against bacteria, and antifungal are used against fungi.

Antimicrobial Resistance:

Antimicrobial resistance happens when microorganisms (such as bacteria, fungi, viruses, and parasites) change when they are exposed to antimicrobial drugs (such as antibiotics, antifungal, antiviral, antimalarials, and anthelmintics). Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.

Session: 2 Antimicrobials and Chemotherapy:

Antimicrobial:

An antimicrobial is an agent that kills microorganisms or stops their growth. Antimicrobial medicines can be grouped according to the microorganisms they act primarily against. For example, antibiotics are used against bacteria, and antifungal are used against fungi.

Chemotherapy:

Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in your body. Chemotherapy is most often used to treat cancer, since cancer cells grow and multiply much more quickly than most cells in the body. Many different chemotherapy drugs are available.

Related Society:

Session 3: Bacterial diseases:

Bacterial disease, any of a variety of illnesses caused by bacteria. Until the mid-20th century, bacterial pneumonia was probably the leading cause of death among the elderly. Improved sanitation, vaccines, and antibiotics have all decreased the mortality rates from bacterial infections, though antibiotic-resistant strains have caused resurgence in some illnesses. In the early 21st century, tuberculosis, which is caused by Mycobacterium tuberculosis—several strains of which had developed resistance to one or more drugs widely used to treat the infection—was among the deadliest infectious diseases worldwide.

Clinical Microbiology Conferences |Bacterial Diseases Conferences | Applied Microbiology Conferences | Medical Microbiology Meetings | Bacterial Disease Events

Related Society:

Session 4: Public Health Microbiology:

Public Health microbiology is a specialty which spans the fields of human, animal, food, water and environmental microbiology, with a focus on human health and disease. It requires laboratory scientists, epidemiologists, and clinicians to generate, integrate, analyze and communicate epidemic intelligence. Public Health microbiology supports the monitoring of known and emerging threats and facilitates the evaluation of effective interventions.

Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. It was initially reported to the WHO on December 31, 2019. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency. On March 11, 2020, the WHO declared COVID-19 a global pandemic, its first such designation since declaring H1N1 influenza a pandemic in 2009. Illness caused by SARS-CoV-2 was termed COVID-19 by the WHO, the acronym derived from "coronavirus disease 2019. " The name was chosen to avoid stigmatizing the virus's origins in terms of populations, geography, or animal associations.

Related Society:

Session 6: Disease Diagnosis and Prevention:

Disease Diagnosis:

Diagnosis, the process of determining the nature of a disease or disorder and distinguishing it from other possible conditions. The term comes from the Greek gnosis, meaning knowledge. Traditionally, diagnosis has been defined as the art of identifying a disease from its signs and symptoms. Formerly, few diagnostic tests were available to assist the physician, who depended on medical history, observation, and examination

Prevention:

Most people know that good hygiene, sanitation and immunizations can prevent infections. They also know if they don’t smoke, eat healthily and exercise regularly they can reduce their chances of developing diabetes or experiencing a heart attack or a stroke. And that if they wear a seatbelt, don’t drink and drive or speed, they are far less likely to be injured or killed on our roads.

Related Society:

Session 7: Fungal Diseases:

Fungal diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis.

Related Society:

Session 8: Host-Pathogen Interactions:

Host pathogen interaction takes place between a pathogen and a host. An asymptomatic infection is the one in which pathogen resides in host without causing any harm; Microbes can be both hosts and pathogens and the studies of bacterial pathogenesis leads to the identification of molecular differences between a pathogenic and a non-pathogenic microbe. Virulence relies on host factors, like pathogenicity of an avirulent microbe in immune compromised host and also the missing of the pathogenicity of virulent pathogens in immune hosts. The measure of virulence is the ability of a microbe to cause disease in any animal, centralized to the Koch’s postulates.

Related Society:

Session 9: Immunity and Vaccination:

Immunity:

The immune system is what protects your body from diseases and infections. It's the bodily system that produces the immune response to defend your body from foreign substances, cells, and tissues. The immune system includes various parts of the body including the thymus, spleen, lymph nodes, special deposits of lymphoid tissue (such as those in the gastrointestinal tract and bone marrow), and macrophages, lymphocytes including the B cells and T cells, and antibodies.

Vaccination:

Injection of a killed microbe in order to stimulate the immune system against the microbe, thereby preventing disease. Vaccinations, or immunizations, work by stimulating the immune system, the natural disease-fighting system of the body. The healthy immune system is able to recognize invading bacteria and viruses and produce substances (antibodies) to destroy or disable them. Immunizations prepare the immune system to ward off a disease. To immunize against viral diseases, the virus used in the vaccine has been weakened or killed. To only immunize against bacterial diseases, it is generally possible to use a small portion of the dead bacteria to stimulate the formation of antibodies against the whole bacteria. In addition to the initial immunization process, it has been found that the effectiveness of immunizations can be improved by periodic repeat injections or "boosters." Also see Vaccines (in the plural) and Vaccine of a specific type (such Vaccine, Polio).

Related Society:

Session 10: Infection Control:

Infection control is the forestalling/prevention of nosocomial infections. It is a part of the framework of the health care. Infection Control and Hospital Epidemiology are pertinent to the public health practice, interpolated in a particular health-care distribution system. Anti-infective agents, like for instance antibiotics - essentially antibacterial, antiviral, antifungal and antiprotozoal are readily accessible to annihilate infections. Infection control comprises elements relevant to the transmission of infections; either in the hospitals or other healthcare centers including prevention via hand hygiene, cleaning or disinfection or sanitization, vaccines or surveillance and probe of infections in a health-care domain and management.

Clinical Microbiology Conferences | Applied Microbiology Conferences | Medical Microbiology Meetings | Infection Control Meetings | Infection Control Conferences

Related Society:

Session 11: Infectious diseases:

Infectious diseases are caused by pathogenic microbes which spread either directly or indirectly from one person to another. These can be classified as either bacterial, viral, zoonotic, parasitic or fungal depending on causative agents. Most of infections are not lethal and organism is annihilated after the symptoms wane. The process requires immune mechanisms to kill the source of the pathogen. Specific acquired immunity antagonistic to the infectious diseases are mediated by either antibodies or by T lymphocytes. The immune response causes high fever, inflammation, and also has the probability to be devastating to a microbe. Phylodynamic models help in locating the epidemic and pandemic origins. The agile rate of evolution and growth in viruses allows molecular clocks to envisage the genetic sequences, thereby providing the precise rate of evolution of the virus.

Related Society:

Session 12: Medical Microbiology:

Medical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

Related Society:

Session 13: Microbial Biofilms:

In most natural, clinical and industrial settings, microorganisms exist in biofilms that associate with biotic and abiotic surfaces. These three-dimensional single-species or polymicrobial communities are embedded in a self-produced matrix that enables the intercellular exchange of metabolites, genetic material and signaling molecules. In addition, these microbial consortia provide protection against predators and antimicrobial agents, and they are widely studied owing to their clinical relevance, their ubiquitous nature and the functional insights that they provide into microbial ecology.

Applied Microbiology Conferences | Medical Microbiology Meetings | Microbiology Workshops and Symposia | Microbial Biofilms Events | Microbial Biofilms Meetings

Related Society:

Session 14: Microbial Epidemiology:

Epidemiology is the study of the determinants, occurrence, and distribution of health and disease in a defined population. Infection is the replication of organisms in host tissue, which may cause disease. A carrier is an individual with no overt disease who harbors infectious organisms. Dissemination is the spread of the organism in the environment.

Related Society:

Session 15: Microbial Infections:

Contamination is the intrusion of a living being's body tissues by ailment causing specialists, their increase, and the response of host tissues to these life forms and the poisons they produce. Diseases are caused by irresistible specialists including infections, viroids, prions, microorganisms, nematodes, for example, parasitic roundworm sand pinworms, arthropods, for example, ticks, bugs, insects, and lice, organisms, for example, ringworm, and different macro parasites, for example, tapeworms and different helminthes. A contamination caused by microorganisms. The development of numerous ailment causing microscopic organisms can be stopped by the utilization of anti-toxins.

Parasitic Infections
Fungal Infections
Viral Infections
Bacterial diseases

Related Society:

Past Conference Report

World Congress on Rare Diseases and Orphan Drugs in Berlin, Germany:

We are thankful to all our wonderful Speakers, Conference Attendees, Students and Associations for making Rare Diseases 2020 Conference the best ever!

10th World Congress on Rare Diseases and Orphan Drugs was held on September 16, 2020; Webinar based on the theme “Explore the Recent Advancements in Rare Diseases Research". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields related to rare diseases, who made this event an outstanding success. Conference Series LLC Ltd expresses its gratitude to all the participants who made this event grad success. Conference Series LLC Ltd offers its heart felt appreciation to keynote speakers, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interweaved with the organisation and supported the conference in every aspect, without which the conference would not have been possible. Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Rare Diseases 2021, Conference Series LLC Ltd would like to announce the commencement of the “11th World Congress on Rare Diseases and Orphan Drugs” to be held in September 06-07, 2021 at Berlin, Germany. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Rare Diseases, Orphan Drugs and Infectious Diseases.

Mark your calendars for the upcoming Conference; we are hoping to see you soon!

International Conference on Emerging Infectious Diseases in Rome, Italy:

With the overwhelming success of the previous conference, Conference Series LLC Ltd hosted 11th International Conference on Emerging Infectious Diseases. The conference was marked with the attendance of Editorial Board Members of supported Conference Series LLC Ltd journals, scientists, young and brilliant researchers, business delegates and talented student communities representing more than 20 countries, who made this conference fruitful and productive.

Conference Series LLC Ltd has taken the privilege of felicitating Emerging Diseases 2020 conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. The esteemed guests, keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Emerging Diseases 2020. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC Ltd, Journal of AIDS & Clinical Research.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the event, Conference Series LLC Ltd would like to announce the commencement of the “12th International Conference on Emerging Infectious Diseases” to be held during October 22-23, 2021 Rome, Italy.

International conference on Parasitology, Microbiology and Infection Control in Paris, France:

We glad to thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Sponsors for making Parasitology 2020 Conference the best ever!

The 8th International Conference on Parasitology & Microbes, hosted by the Conference series LLC ltd was held during December 03-04, 2020 Rome, Italy based on the theme “Advanced Research Developments and Methodologies to treat Parasitic Disorders". Gracious response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Microbiology, Infectious Diseases, Pathology and Immunology who made this event a grand success.

Conference series LLC ltd expresses its gratitude to the conference Moderator for taking up the responsibility to coordinate during the sessions. We are indebted to your support. Very special thanks to our Sponsors to have bestowed and their faith and invested in us to make this event a fruitful one. We hope you continue your support in our future endeavours. The conference was initiated with the Honourable presence of the Keynote forum With the grand success of Parasitology 2020, Conference Series LLC ltd is proud to announce the " 9th International conference on Parasitology, Microbiology and Infection Control" to be held during November 08-09, 2021 Paris, France.

International Conference on Tropical Diseases and Cure in Zurich, Switzerland:

Intercontinental Conference on Bacteriology and Infectious Diseases in Edinburgh, Scotland:

On the formidable success of the Bacteriology 2019, announces the next in the series of Infectious diseases and bacteriology conferences i.e. Bacteriology 2020. The 10th International Conference on Bacteriology and Infectious Diseases welcomes you to utilize the opportunity to network with the international expertise, Research Heads, Medical Associations and Organizations who are joining hands with aiming in spread of knowledge in the field of Bacteriology and Infectious Diseases. The Bacteriology 2020 scheduled on October 26-27, 2020 in Cape Town, South Africa is setting a stage for all the people indulged into the fields of Microbiology, Immunology, Pathology and Infectious Diseases to present their research works or to share their ideology which may in turn lead to a revolutionary change in the respective fields.

To Collaborate Scientific Professionals around the World

Conference Date May 27-28, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Supported By

Archives of Clinical Microbiology (ISSN: 1989-8436) Medical Mycology: Open Access Journal of Infectious Diseases & Therapy: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Clinical Microbiology and Infectious Diseases

May 27-28, 2022 Rome, Italy

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Renowned Speakers

Dr Ovidiu Zlatian

Mr Vincent Xin

Dr Charles Ologunde

Recommended Global Microbiology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Euro Clinical Microbiology 2022

Euro Clinical Microbiology 2022

About

Market Analysis

Scientific Sessions

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Supported By